Adverse events after endobronchial implantation of valves in 3 months follow-up
| Adverse event | DLCO ≤20% pred | DLCO >20% pred | p-value |
| Subjects n | 26 | 65 | |
| ICU | 1 (3.8) | 3 (4.6) | 0.93 |
| Mechanical ventilation | 0.0 | 3 (4.6) | 0.28 |
| Death | 0 | 0 | |
| Sepsis | 0 | 0 | |
| Bleeding | 0.0 | 1 (1.5) | 0.54 |
| Pneumonia | 0.0 | 2 (3.1) | 0.39 |
| AECOPD | 1 (3.8) | 13 (20.0) | 0.07 |
| Pneumothorax | 6 (23.1) | 14 (21.5) | 0.73 |
Data are presented as n (%) unless otherwise stated. DLCO: diffusion capacity of the lung for carbon monoxide; ICU: intensive care unit; AECOPD: acute exacerbation of chronic obstructive pulmonary disease.